Editorial: Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Still No Evidence of Specific Effects
Journal of the American Academy of Child & Adolescent Psychiatry · 2023
DOI: 10.1016/j.jaac.2023.01.002 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of the American Academy of Child & Adolescent Psychiatry, 2023. Verfasst von Diane Purper-Ouakil. Beteiligte Einrichtung: Saint Eloi Hospital, University of Montpellier, Montpellier, Hérault, France. Electronic address: d-purper_ouakil@chu-montpellier.fr. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Neurofeedback. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Saint Eloi Hospital, University of Montpellier, Montpellier, Hérault, France. Electronic address: d-purper_ouakil@chu-montpellier.fr.
Förderung
- Horizon 2020 Framework Programme
Zitieren
APA
Purper-Ouakil, D. (2023). Editorial: Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Still No Evidence of Specific Effects. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2023.01.002
Vancouver
Purper-Ouakil D. Editorial: Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Still No Evidence of Specific Effects. Journal of the American Academy of Child & Adolescent Psychiatry. 2023. doi:10.1016/j.jaac.2023.01.002
BibTeX
@article{PurperOuakil2023,
author = {Purper-Ouakil, Diane},
title = {Editorial: Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Still No Evidence of Specific Effects},
journal = {Journal of the American Academy of Child & Adolescent Psychiatry},
year = {2023},
doi = {10.1016/j.jaac.2023.01.002}
}
EUVIMED